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1. Introduction
With the increasing number of patients suffering from damaged or diseased organs and the
shortage of organ donors, the need for methods to construct human tissues outside the body
has arisen. Tissue engineering is a newly emerging biomedical technology and methodology
which combines the disciplines of both the materials and life sciences to replace a diseased
or damaged tissue or organ with a living, functional engineered substitute [1, 2]. The so-
called triad in tissue engineering encompasses three basic components called scaffold, cell
and signaling biomolecule.
Whatever the approach being used in tissue engineering, the critical issues to optimize any
tissue engineering strategy toward producing a functional equivalent tissue are the source
of the cells and substrate biomaterial to deliver the cells in particular anatomical sites where
a regenerative process is required. Due to their unique properties, stem cells and polymeric
biomaterials are key design options. Briefly, stem cells have the ability to self-renew and
commit to specific cell lineages in response to appropriate stimuli, providing excellent re‐
generative potential that will most likely lead to functionality of the engineered tissue. Poly‐
meric materials are biocompatible, degradable, and flexible in processing and property
design. A major focus of tissue engineering, therefore, is to utilize functional polymers with
appropriate characteristics, as a means of controlling stem cell function. Based on their dif‐
ferentiation potential, stem cells used for tissue engineering can be divided into two catego‐
ries: pluripotent stem cells and multipotent stem cells. Pluripotent stem cells include
embryonic stem cells (ESCs) as well as induced pluripotent stem cells (iPSCs). Because ESCs
are isolated from the inner cell mass of the blastocyst during embryological development,
their use in tissue engineering is controversial and more limited while more attention has
been paid to adult stem cells, which are multipotent and have a larger capacity to differenti‐
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ate into a limited number of cell types [3]. Adult stem cells can be found in many adult tis‐
sue types including bone marrow, peripheral blood, adipose tissues, nervous tissues,
muscles, dermis, etc. For instance, mesenchymal stem cells (MSCs) which reside in the bone
marrow can differentiate into bone (osteoblasts) [4], muscle (myoblasts) [5], fat (adipocytes)
[6] and cartilage (chrondocytes) [3] cells, while neural stem cells (NSCs) either give rise to
support cells in the nervous system of vertebrates (astrocytes and oligodendrocytes) or neu‐
rons [7]. In vivo, differentiation and self-renewal of stem cells are dominated by signals from
their surrounding microenvironment [8]. This microenvironment or “niche” is composed of
other cell types as well as numerous chemical, mechanical and topographical cues at micro-
and nano-scales, which are believed to serve as signaling mechanisms to determine cell-spe‐
cific recruitment, migration, proliferation, differentiation as well as the production of
numerous proteins required for hierarchical tissue organization [9].
In vivo, the cells are surrounded by a biological matrix comprising of tissue-specific combi‐
nations of insoluble proteins (e.g. collagens, laminins, and fibronectins), glycosaminoglycans
(e.g. hyaluronan) and inorganic hydroxyapatite crystals (in bone) that are collectively refer‐
red to as the extracellular matrix (ECM). The varied composition of the ECM components
not only contains a reservoir of cell-signaling motifs (ligands) and growth factors that guide
cellular anchorage and behavior, but also provides physical architecture and mechanical
strength to the tissue. The spatial distribution and concentration of ECM ligands, together
with the tissue-specific topography and mechanical properties (in addition to signals from
adjacent cells—juxtacrine signalling—and the surrounding fluid), provide signaling gradi‐
ents that direct cell migration and cellular production of ECM constituents. In this dynamic
environment, the bidirectional flow of information between the ECM and the cells mediates
gene expression, ECM remodeling and ultimately tissue/organ function.
Native  ECM  exhibits  macro-  to  nano-scale  patterns  of  chemistry  and  topography  [10].
Tissue stiffness is also known to vary depending on the organ type, disease state and ag‐
ing process [11-13].  In tissue culture, stem cell  differentiation has traditionally been con‐
trolled by the addition of soluble factors to the growth media [14]. However, most stem
cell  differentiation  protocols  yield  heterogeneous  cell  types  [15,  16].  Moreover,  cells  en‐
counter  very  different,  unfamiliar  surfaces  and  environments  when  cultured  in  vitro  or
when materials are implanted into the body. Therefore, it is desirable to use more biomi‐
metic in vitro  culture conditions to regulate stem cell fate so as to advance clinical trans‐
lation  of  stem  cells  through  better  expansion  techniques  and  scaffolding  for  the
regeneration  of  many  tissues.  Recent  advances  have  facilitated  further  the  creation  of
substrates  with  precise  micro-  and  nano-cues,  variable  stiffness  and  chemical  composi‐
tion to better mimic the in vivo  microenvironment [2, 17, and 18]. By employing various
novel  approaches,  tissue  engineers  aim  to  incorporate  topographical,  mechanical  and
chemical cues into biomaterials to control stem cell fate decisions [2, 18, and 19].
This chapter will  present various biomaterial  designing considerations and strategies for
stem cell-based tissue engineering for  development  as  carriers  for  stem cells  facilitating
the in vivo use of stem cells in tissue engineering. This part first presents some biomimet‐
ic  approaches  to  designing  novel  polymeric  biomaterials  with  appropriate  physical,
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chemical, mechanical, and biological cues mimicking the natural stem cell niche in order
to  direct  the  desired  stem  cell  behavior  to  facilitate  the  regeneration  of  desired  tissues
with particular emphasis on using adult stem cells including MSCs and NSCs. The next
part will introduce some new trends emerging in the field of tissue engineering in terms
of both cellular biology and biomaterial point of view in order to improve the overall ef‐
ficiency of  tissue regeneration for effectively controlling the cell  fate and translating the
stem cell research into much needed clinical applications in a not-too-distant future. The
topics discussed in the latter part include 2D polysaccharide-based hydrogel scaffolds de‐
signed in the authors'  studies for muscle tissue engineering applications.  Hydrogel scaf‐
folds  made  of  natural  polymers  with  proper  handling  for  surgery  and  mechanical
properties  similar  to  muscle  tissue,  which  could  promote  the  desired  muscle-derived
stem cell behavior on the surface were developed in this study.
2. Biomimetic microenvironment design strategies
Damaged tissues often lose deeper layers which contain stem cell niches. In such cases, bio‐
materials could be useful tools for reestablishing the niches' functionality [20]. Artificial
niches would need to incorporate appropriate ‘homing’ signals able to either localize endog‐
enous stem cells or direct the desired incorporated exogenous stem cell behavior by means
of developing various microenvironment design parameters including the dynamic control
of soluble and surface-bound cytokines, ECM, cell-cell interactions, mechanical forces and
physicochemical cues [21, 22].
The  use  of  biomaterials  as  scaffolds  is  a  fundamental  component  of  tissue  engineering
since these materials serve as templates for tissue formation and are engineered depend‐
ing on the tissue of  interest.  These scaffolds provide structural  and mechanical  support
for  the  cells  as  well  as  present  cues  inducing  tissue  repair.  The  structure,  morphology,
degradation and presentation of  bioactive sites  are  all  important  parameters  in  material
design for these applications and may signal  the differentiation of  stem cells.  Beside all
the parameters related to the biomaterials  scaffold,  there are some other factors such as
chemical  cues  (e.g.  soluble  reagents  in  terms  of  both  concentration  and  their  gradient,
medium pH),  mechanical  cues  (e.g.  fluid  shear  stress)  and other  types  of  cues  (electric
and magnetic  field)  which are  believed to  have significant  effect  on stem cell  behavior.
These factors are reviewed extensively elsewhere [23, 24].
Figure 1 summarizes the biomimetic microenvironment design strategies for controlling
stem cell behavior including chemical/biochemical (e.g. growth/differentiation factor presen‐
tation, density and gradient), structural, mechanical and some other types of cues.
Engineering these design parameters will effectively yield materials that create an architec‐
ture resembling the native environment for stem cells, and have controlled mechanical prop‐
erties enabling adhesion and thus enhancing contractility in the cellular cytoskeleton, and
present ligands directing intracellular signaling and gene expression. This section provides
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an overview of biomimetic microenvironment design strategies to direct the stem cell behav‐
ior for tissue engineering applications.
Figure 1. The biomimetic microenvironment design strategies for controlling stem cell fate
2.1. Chemical and biochemical cues
Biochemical cues are generally provided by soluble ligands, which may be either secreted
by paracrinal cells or supplied by a capillary network in the human body. Insoluble ligands,
which are adhesion proteins or molecules such as collagen, laminin and carbohydrates, are
also present. Biochemical factors typically influence the cell microenvironment in a concen‐
tration or gradient-dependent manner.
Chemical  and biochemical  means are  the  first  choice  for  stem cell  differentiation.  Small
ions, growth factors, and cytokines can exert potent, long-range effects over stem cell mi‐
croenvironments.  Owing to their  relative ease of  study,  soluble  biochemical  cues  and their
downstream  signal  transduction  pathways  are  the  best  characterized  determinants  of
stem cell fate and have been extensively used in ex vivo  stem cell culture systems, as ex‐
tensively discussed elsewhere [24-26].  Therefore,  the following section will  mainly focus
upon the application of other types of soluble signals such as dissolved oxygen as well as
insoluble  chemical  and  biochemical  cues  (e.g.,  immobilized  growth  factor,  extracellular
matrix material, etc) to engineered niches.
In vivo, numerous growth factors and morphogens are immobilized by binding to the ECM
through specific heparin-binding domains or by direct binding to ECM molecules such as
collagen, or direct anchoring to cell membranes [27]. Immobilization of growth factors in
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this manner can serve to increase local concentration of the protein by hindering diffusion
and receptor-mediated endocytosis. For example, the morphogen Sonic hedgehog (Shh) is
modified at its termini by lipids that link it to the cell membrane and thereby limit its mobi‐
lity. Removing the lipids dilutes the factor to a lower concentration and thereby shrinks its
effectiveness [28, 29]. Accordingly, mimicking the natural immobilization of cytokines is one
approach utilized by engineers to concentrate factors in proximity to the cell surface in a
manner that activates target signaling pathways effectively, and reduces, as well, the levels
of growth factor necessary to elicit a potent cellular response.
An early study exploring this design concept focused on epidermal growth factor (EGF) [30]
which is beneficial in repairing the damaged tissues, but is often difficult to deliver at suffi‐
ciently high concentrations to mediate downstream signaling events as it does not contain a
matrix-binding domain and rapidly undergoes receptor-mediated endocytosis [31]. In a re‐
cent example involving human and porcine MSCs, amine-targeting chemistry was used to
tether EGF to the surface of poly (methyl methacrylate)-graft-poly (ethylene oxide) comb
polymers [32]. The tethered EGF led to sustained EGF receptor signaling and subsequent
cellular responses including cell spreading and protection from apoptosis, whereas saturat‐
ing levels of soluble EGF did not. Sakiyama-Elbert et al. incorporated heparin into biomate‐
rial scaffolds to allow for immobilization of basic fibroblast growth factor (bFGF) [33]. bFGF
was released either passively by diffusion, or actively via heparinases secreted by neighbor‐
ing cells, thereby allowing for a controlled release and presentation of signal which was not
possible with soluble growth factor delivery. The same delivery system has been used for
differentiation of murine ESCs into mature neural cell types, including neurons and oligo‐
dendrocytes, indicating that biomaterials scaffolds functionalized with immobilized growth
factors may be a potential strategy for generation of engineered tissue for treatment of spi‐
nal cord injury [34]. Finally, in a recent study, polymer substrates functionalized with the
signaling domain of Shh supported enhanced osteogeneic differentiation of bone marrow-
derived MSCs, as compared to cells cultured on the same surfaces with soluble Shh at the
same concentration [35]. This example further demonstrates how growth factor or morpho‐
gen immobilization serves as an effective means to achieve sustained activation of down‐
stream signaling pathways due in part to the finding that the local concentration in the
scaffold was greater for immobilized growth factor than for soluble form.
There is a significant scope in the application of surface modifications, despite the use of
protein biomolecules to provide more cues for cell adhesion, proliferation and differentia‐
tion. Arg-Gly-Asp (RGD) sequence and several natural proteins like collagen, laminin and
fibronectin were shown to be essential for cell attachment to polymeric material surfaces de‐
void of any cell recognition sites [36, 37]. The immobilization of these proteins to polymers
not only promotes cell adhesion and proliferation but also increases hydrophilicity of the
polymers such as aliphatic polyesters. One such surface functionalization for biopolymer
substrate surfaces is attachment of RGD peptides that is the most effective and often em‐
ployed peptide sequence for stimulating cell adhesion on synthetic polymer surfaces. This
peptide sequence can interact with integrin receptors at the focal adhesion points. Once the
RGD sequence is recognized by the integrins, it will initiate an integrin-mediated cell attach‐
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ment pathway and activate signal transduction between the cell and ECM, thus influencing
various cell behaviors on the substrate including proliferation, differentiation, survival and
migration [38]. Roeker et al. showed that the composite materials modified by immobilizing
poly-L-lysine and BMP-2 as bioactive ligands on the ceramic surface had promising poten‐
tial to enhance the adhesion of hMSCs and directing cell differentiation into osteoblasts [39].
In another study, it was demonstrated that hMSCs encapsulated in poly (ethylene glycol)
(PEG)/ RGD hydrogels undergo chondrogenic differentiation in the presence of TGF-β3.
More importantly, this effect has been found to be RGD-dose dependent and there is an op‐
timal concentration of RGD present in PEG hydrogels, which improves cell viability and
promotes chondrogenesis [40].
In spite of the addition of differentiation factors in the culture media, the matrix materials
which support the cells affect the differentiation of stem cells as well. Mauney et al. found
that the matrix-denatured collagen type I is more capable in retaining the osteogenic differ‐
entiation potential in vitro and even bone-forming capacity in vivo of hMSCs than the con‐
ventional tissue culture plastic [41]. Mwale et al. discerned that bi-axially oriented
polypropylene plasma treated in ammonia reduced upregulation of the expression of osteo‐
genic marker genes, such as alkaline phosphatase (ALP), bone sialoprotein and osteocalcin
significantly [42]. According to a report presented by Ager et al. [43], collagen I/III and
PLLA porous scaffolds showed certain osteoinductive properties without Dex, ascorbic acid,
and βGP (DAG) stimulation, verified by immunocytochemical staining against osteoblast-
typical markers and completed by calcified matrix detection. Wang et al. demonstrated that
ascorbic acid-functionalized poly (methyl methacrylate) can modulate the proliferation and
osteogenic differentiation of early and late-passage bone marrow-derived hMSCs [44].
More recently, Xu et al. showed that hMSCs attached, and subsequently proliferated and
differentiated toward the osteogenic lineage on the biomimetic bioglass-collagen-hyaluronic
acid-phosphatidylserine (BG-COL-HYA-PS) composites to a significantly higher degree
compared to those cells on the BG-COL, BG-COL-HYA composites, suggesting the BG-COL-
HYA-PS composite porous scaffolds have high potential for bone tissue engineering [45]. In
another study, it was shown that the incorporation of gelatin in the poly [(L-lactide)-co-(e-
caprolactone)] (PLCL) nano-fibers stimulated the adhesion and osteogenic differentiation of
hMSCs, suggesting that the chemical composition of the underlying scaffolds play a key role
in regulating the osteogenic differentiation of hMSCs [46].
Regarding  chondrogenic  differentiation,  investigating  the  effect  of  cartilage-tissue  chon‐
droitin-sulfate  (CS)  in  a  fibrin  scaffold  on  the  differentiation  of  adipose-derived  adult
stem cells into chondrocytes revealed the significant effect of CS on the differentiation ef‐
ficiency.  It  can  be  concluded that  the  fibrin–CS matrices  mimicking native  cartilage  ex‐
tracellular  matrix  could  act  as  a  three-dimensional  scaffold  for  cartilage  tissue
engineering and have the  potential  for  promoting the  differentiation of  adipose-derived
adult stem cells into chondrocytes [47].
Since the chemical  properties of  substrates (e.g.,  hydrophobicity)  play an important role
in the kinetics of protein adsorption and folding, which in turn influence cellular activi‐
ties,  direct  the  stem  cells’  fate  can  be  controlled  by  chemical  modification  of  the  sub‐
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strate.  Surface  modification  techniques  such  as  plasma  treatment,  ion  sputtering,
oxidation and corona discharge affect  the chemical  and physical  properties  of  the poly‐
mer  surface  without  significantly  changing  the  bulk  material  properties.  For  example,
plasma processes makes it possible to change the chemical composition and properties of
the  polymer  system such  as  hydrophobicity,  surface  energy,  refractive  index,  hardness,
chemical inertness and biocompatibility [48]. Plasma techniques can easily be used to in‐
duce the desired groups or chains onto the surface of a polymer [49, 50]. Appropriate se‐
lection of  the  plasma source  facilitates  the  introduction of  diverse  functional  groups on
the polymer surface to improve biocompatibility or to allow subsequent covalent immo‐
bilization of various bioactive cues. For instance, plasma treatments with oxygen, ammo‐
nia,  or  air  can  generate  carboxyl  groups  or  amine  groups  on  the  polymer  surface  [51,
52].  A variety of ECM protein components such as gelatin,  collagen, laminin,  and fibro‐
nectin  could  be  immobilized  onto  the  plasma-treated  surface  to  enhance  cellular  func‐
tions [53]. Curran et al. show that stem cell differentiation is guided by surface chemistry
and energy, independent of inductive media [54]. Although all the surfaces tested main‐
tained cell viability, silanized hydrophobic surfaces with CH3  end groups (with low sur‐
face  energy)  maintain  MSC  phenotype,  while  increasing  the  surface  energy  by  adding
NH2-  or  SH- terminal  groups promotes  osteogenesis.  Further  increase of  surface  energy
by addition of OH or COOH moieties promotes chondrogenesis.  However,  there are re‐
ports  indicating  that  both  hydrophobicity  and  surface  energy  play  a  role  in  cell  adhe‐
sion,  but  only  in  the  short  term  until  cells  themselves  modulate  their  extracellular
environment [55, 56].
Probably one of the best known soluble reagents is dissolved oxygen. Typical oxygen con‐
centrations in vivo vary from 12.5 to 5%, whilst the oxygen concentration in cell culture incu‐
bators is the same as that in the air, which is 20%. Several reports show that lowered oxygen
concentrations (5%) increase stem cell proliferation [57-59]. Grayson et al. [60] have shown
that even lower oxygen concentrations of about 2% increase MSC proliferation whilst main‐
taining an undifferentiated state, thus suggesting that hypoxic conditions are the character‐
istic of the niche environment. Some authors have observed an induction of adipose-like
phenotype in MSCs in severe hypoxia (1%) [61], whilst others showed that adipogenesis is
suppressed at 6% oxygen compared to 20% oxygen [62]. Lennon et al. reported that rat
MSCs exposed to 5% oxygen during amplification show enhanced osteogenesis after im‐
plantation, compared with cells amplified in 20% which may probably be due to increased
proliferation as suggested above [63]. Buckley et al. showed the beneficial response of chon‐
drocyte cells to a low oxygen environment in the absence of TGF-β, suggesting that hypoxia
can be used as an alternative to growth factor stimulation to engineer cartilage from culture-
expanded chondrocyte [64].
2.2. Structural cues
Biomaterial scaffolds take on a variety of structures based on their material composition and
processing for forming 3D environments. These materials consist of natural polymers such
as collagen, hyaluronic acid, fibrin, alginate, or synthetic polymers such as polyethylene gly‐
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col (PEG), dextran, or polyvinyl alcohol and can be formed into hydrogels, fibrous struc‐
tures, and microporous scaffolds [65,66]. Figure 1 illustrates examples of the structure of
each of these scaffold types. The biomaterial structure controls how a cell interacts with the
material and is important in stem cell fate decisions as the presentation of cues and cellular
morphology are dependent on this structure.
Hydrogels  are comprised of  insoluble networks of  cross-linked polymers with high wa‐
ter contents [67]. Hydrogels with the ability to encapsulate stem cells have been used for
applications such as cartilage [68, 69] and cardiac [70, 71] tissue regeneration. In order to
achieve  tissue  formation,  stem cells  must  either  be  encapsulated  within  or  recruited  to
the hydrogel.  Some recently  reported applications  of  hydrogel  in  tissue engineering are
presented the following part.
Hydrogels such as those derived from alginate, collagen and hyaluronic acid have been
found to be quite promising – they provide a homogeneous, structureless soft 3D environ‐
ment which is probably ideal for stem cell proliferation and maintenance, as well as for dif‐
ferentiation into softer tissues such as neural or hepatic [72, 73]. Pranga et al. showed the
promotion of oriented axonal regrowth in the injured spinal cord by alginate-based aniso‐
tropic capillary hydrogels [74]. In a recent study, Nguyen et al. demonstrated that a three-
layer polyethylene glycol-based hydrogel creates native-like articular cartilage with
spatially-varying mechanical and biochemical properties that can direct a single MSC popu‐
lation to differentiate into the superficial, transitional, or deep zones of articular cartilage.
They concluded that spatially-varying biomaterial compositions within single 3D scaffolds
can stimulate efficient regeneration of multi-layered complex tissues from a single stem cell
population. The ability to generate such zone-specific tissue could eventually allow tissue-
engineering of more native-like articular cartilage substitutes with spatially varying ECM
composition and mechanical properties [75, 76]. Moreover, injectable hydrogels have been
extensively explored as cell delivery systems with the advantage that cells and biomolecules
can be readily integrated into the gelling matrix [77, 78]. The injectable nature of the hydro‐
gels provides the attractive feature of facile and homogenous cell distribution within any de‐
fect size or shape prior to gelation. In addition, injectable hydrogels allow good physical
integration into the defect and facilitating the use of minimally invasive approaches for ma‐
terial delivery [79, 80]. Tan et al. demonstrated the usefulness of the aminated hyaluronic
acid-g-poly (N isopropylacrylamide) copolymer as an injectable hydrogel for adipose tissue
engineering [81]. Recently, Tan et al. demonstrated that the thermo-sensitive alginate-based
injectable hydrogel has attractive properties that make it suitable as cell or pharmaceutical
delivery vehicles for a variety of tissue engineering applications [82].
Although hydrogels provide a highly controlled 3D microenvironment for cells, the nature
of this scaffold does not entirely mimic the structure of native ECM. Generally the cells en‐
counter and respond to basement membrane topography in the in vivo environment mainly
composed of networks of pores, ridges, and fibers made by ECM molecules such as colla‐
gen, fibronectin and laminin at length scales ranging from nano- to micro-scale [83]. It is
therefore important to incorporate features at such length scales into the development of bi‐
omaterials suitable for stem cell therapies.
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One of the most widely used biomaterial structures for tissue engineering involves micropo‐
rous scaffolds, which can form interconnected porous networks that allow for cellular infil‐
tration and tissue formation. These scaffolds are often formed with leachable components
around which the desired polymer forms a scaffold [84]. Upon removal of the leachable
components, a 3D structure can be obtained with varying parameters such as pore size, po‐
rosity, and interconnectivity. Aronin et al. created poly-(e-caprolactone) scaffolds with var‐
ied pore sizes and interconnectivity to monitor osteogenesis of dura mater stem cells [85].
High porosity and adequate pore-size are key requisites to increase the surface area availa‐
ble for cell attachment and tissue in-growth in order to facilitate the uniform distribution of
cells and the adequate transport of nutrients. Murphy et al. has investigated the effect of
mean pore size on cell behavior in collagen–glycosaminoglycan scaffolds for bone tissue en‐
gineering application [86]. The results show that cell number was highest in scaffolds with
the largest pore size of 325 μm. While the increased surface area provided by scaffolds with
small pores may have a beneficial effect on initial cell adhesion but ultimately the improved
cellular infiltration provided by scaffolds with larger pores outweighs this effect and sug‐
gests these scaffolds might be optimal for bone tissue repair. Kasten et al. also showed that
porosity, distribution and size of the pores of beta-tricalcium phosphate ceramic scaffold can
influence protein production and osteogenic differentiation of hMSCs [87]. Tayton et al.
have compared the porous and non-porous versions of poly (DL-lactide) for potential clini‐
cal use as alternatives to allografts in impaction bone grafting [88]. The results showed that
the skeletal stem cells differentiated along the osteoblastic lineage in porous samples com‐
pared to the non-porous versions. This feature may result from the fact that the 3D micro-
architecture could distribute cellular binding sites in a variety of specific spatial locations
rather than on only the single plane of rigid substrate, as in traditional two-dimensional 2D
architecture of cell culture plastic or the surface of the non-porous polymers. Cells, there‐
fore, may have cytoskeletal adaptor proteins on a 3D matrix in addition to proteins present
in 2D focal adhesions [89, 90]. Such differences in cell adhesion on the porous and non-po‐
rous polymers may therefore lead to different signal transduction and subsequent alteration
in cellular rearrangement.
Natural ECM consists of various protein fibrils and fibers interwoven within a hydrated
network of glycosaminoglycan chains [91].  The nano-scale structure of the ECM offers a
natural network of intricate nano-fibers to support cells and present an instructive back‐
ground  to  guide  their  behavior  [92-94].  Each  nano-fiber  provides  the  way  for  cells  to
form tissues as complex as bone, liver, heart, and kidney. Researchers try to fabricate fi‐
bers to mimic the natural ECM as a support for cell growth. The proliferation and osteo‐
genic  differentiation of  MSCs was  investigated in  3D non-woven fabrics  prepared from
polyethylene terephthalate (PET) microfiber by Takahashi et al. They showed that the at‐
tachment, proliferation and bone differentiation of MSCs were influenced by the fiber di‐
ameter  and  porosity  of  non-woven  fabrics  in  the  scaffolds  [95].  Several  reports  have
demonstrated that  nano-fibers  are more favorable than micro-fibers,  suggesting that  cell
activities can further be regulated by the size of the fiber [96-98] in terms of the biologi‐
cal  response  of  chondrocytes,  NSCs  and  endothelial  cells  cultured  on  nanofibrous  and
microfibrous  scaffolds.  Although the  mechanisms by which a  nano-fibrous  scaffold  acts
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as a selective substrate are not known yet, it is clear that the enhanced adsorption of cell
adhesion matrix  molecules  enhances cell  adhesion.  Xin et  al.  also confirmed that  PLGA
nano-fibers accommodate the survival and proliferation of human MSCs. hMSCs, as well
as hMSC-derived chondrogenic and osteogenic cells,  apparently attach to PLGA nano-fi‐
bers, and yet assume different morphological features [99]. These results demonstrate the
full  support  of  multi-lineage  differentiation  of  MSCs  within  nano-fibrous  scaffolds  and
the  feasibility  of  multi-phasic  tissue  engineering  constructs  using  a  single  cell  source,
which  is  of  particular  relevance  to  the  development  of  multi-phasic  tissue  constructs.
However,  there  are  very  few  in-depth  studies  on  nano-fiber  topographical  effects  on
stem cell differentiation. Other nano-scaled topographical features such as steps, grooves,
pillars and pits also modulate cell behavior, as reviewed elsewhere [100].
Currently, there are three techniques available for the synthesis of nano-fibers: electrospin‐
ning, self-assembly, and phase separation. In particular, electrospinning technique is the
most widely studied technique which has attracted wide attention due to its applicability for
a variety of synthetic and natural polymers, exhibiting the most promising results for tissue
engineering applications. Electrospinning is a spinning method to generate submicron to
nanometer scale fibers from polymer melts or solutions. It is a physical process to obtain fi‐
bers from a bulk polymer of interest under the applied electric field. The most commonly
used polymers for nano-fiber fabrication using electrospinning are the aliphatic polyesters
[101]. There are several reports describing the potential of nanofibers fabricated by electro‐
spinning method for neural [102-104], bone [105-108] and cartilage [109, 110] tissue engi‐
neering which mimic the native tissue environment and support the cell adhesion,
proliferation and differentiation.
Nano-fibers hold great promise as potential scaffolds owing to their high porosity and high
surface area-to-volume ratio, which are favorable parameters for cell attachment, growth,
and proliferation in addition to possessing favorable mechanical properties [111]. Further‐
more the effect of nano-fibers for stem cells’ differentiation is promising further applications
of nano-fibers for tissue engineering. Stem cells can be induced to differentiate into different
cell types by growth/differentiation factors in the media, and we can incorporate such bio‐
molecules into the nano-fibers to direct differentiation to a desired cell type. The biomimetic
morphology of nano-fibers with different patterns may also help to direct the stem cells’ dif‐
ferentiation, which is particularly attractive given differentiation induction by some of me‐
dium supplements, although successful, is not physiologically relevant and offers the
possibility for development of improved clinical prostheses with topographies that can di‐
rectly modulate stem cell fate.
2.3. Mechanical cues
Importantly, the various tissues of the body exhibit a range of matrix stiffness, and such
differences in substrate stiffness have long been known to influence cell fate decisions in
differentiated cell  types [112].  An emerging area of study in stem cell  biology and engi‐
neering is  investigation of  the  role  of  these  mechanical  cues  in  stem cell  fate  decisions.
Because MSCs can differentiate in vitro  into cell types from tissues ranging from muscle,
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bone, and potentially brain, it can be hypothesized that the mechanical cues provided by
the  ECM  are  particularly  instructive  in  lineage  specification.  The  study  carried  out  by
Engler et al. revealed that matrix elasticity influences differentiation of hMSCs into osteo‐
genic, myogenic, and neurogenic cells [113]. Softer gels (0.1–1 kPa) were neurogenic, the
hardest (24–40 kPa) were osteogenic, and the gels with intermediate elastic moduli (8–17
kPa)  were  myogenic.  In  all  three  cases,  the  elastic  modulus  matches  that  of  the  corre‐
sponding native tissue. It has recently been found out that substrate stiffness collaborates
with soluble medium conditions to regulate the proliferation and differentiation of adult
NSCs [114]. Cells exhibit optimum proliferation (in FGF-2) and optimum neuronal differ‐
entiation  (in  retinoic  acid)  at  an  intermediate  stiffness  that  is  characteristic  of  brain  tis‐
sue.  Furthermore,  under  conditions  that  induce  nonspecific  cell  differentiation,  stiff
substrates  support  the  differentiation  of  GFAP-expressing  astrocytes,  whereas  soft  sub‐
strates preferentially support the differentiation of β-tubulin III expressing neurons. This
research demonstrates how the mechanical and biochemical properties of an adult NSCs
microenvironment can be tuned to regulate the self-renewal and differentiation of  adult
NSCs.  In  another  study,  Leipzig  et  al.  demonstrated that  an optimal  stiffness  exists  for
both  proliferation  (3.5  kPa)  as  well  as  differentiation  of  neural  stem/progenitor  cell  to
neurons (<1 kPa) [115].
The study conducted by Banerjee et al. [116] provided insights into the influence of the me‐
chanical properties of 3D alginate hydrogel scaffolds on the proliferation and differentiation
of NSCs, where varying the concentrations of alginate and calcium chloride provided facile
control over the elastic modulus of the hydrogels. They demonstrated that the properties of
the 3D scaffolds significantly impacted both the proliferation and the neuronal differentia‐
tion of encapsulated NSCs. In addition, they observed the greatest enhancement in expres‐
sion of the neuronal marker β-tubulin III within hydrogels having an elastic modulus
comparable to that of brain tissues. They noted that the optimal value of the elastic modulus
might depend on the stem cell type and the lineage to which differentiation is being direct‐
ed. Wang et al. reported an injectable hydrogel scaffold composed of gelatin-hydroxyphe‐
nylpropionic acid conjugate system with tunable stiffness for controlling the proliferation
rate and differentiation of hMSCs in a 3D context in normal growth media. The rate of
hMSC proliferation increased with the decrease in the stiffness of the hydrogel. Also, the
neurogenesis of hMSCs was controlled by the hydrogel stiffness in a 3D context without the
use of any additional biochemical signal. These cells which were cultured for 3 weeks in hy‐
drogels with lower stiffness expressed much more neuronal protein markers compared to
those cultured in stiffer hydrogels for the same period of time [117]. In another study, lower
cross-linked matrix of hydrogel system comprising hyaluronic acid-tyramine conjugates en‐
hanced chondrogenesis with increases in the percentage of cells with chondrocytic morphol‐
ogy, biosynthetic rates of glycosaminoglycan and type II collagen, and hyaline cartilage
tissue formation. By increasing cross-linking degree and matrix stiffness, a shift in MSC dif‐
ferentiation toward fibrous phenotypes with the formation of fibrocartilage and fibrous tis‐
sues was observed [118]. In general, the ability to control stem cell fate – possibly without
the use of chemical inducers – would be broadly useful for applications in regenerative
medicine and tissue engineering [116].
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Except mechanical properties of the matrix, the external mechanical stimulus can also in‐
duce stem cell differentiation. Bioreactors provide various active environments for stem cell
growth under specific mechanical conditions. Flow perfusion culture of scaffold/cell con‐
structs has been witnessed to enhance the osteoblastic differentiation of rat MSCs over static
culture in the presence of osteogenic supplements such as Dex. Although Dex is known to
be a powerful induction agent of osteogenic differentiation in MSCs, Holtorf et al. showed
that the mechanical shear force caused by fluid flow in a flow perfusion bioreactor would be
sufficient to induce osteoblast differentiation in the absence of Dex [119]. Flow perfusion al‐
so accelerates the proliferation and differentiation of rat MSCs seeded on non-woven PLLA
microfibrous scaffolds toward the osteoblastic phenotype, and improves the distribution of
the calcified extracellular matrix generated in vitro [120]. Li et al. reported that MSCs are also
mechano-sensitive and that Ca2+ may play a role in the signaling pathway since MSCs sub‐
jected to oscillatory fluid flow exhibited increased intracellular Ca2+ mobilization [121]. More
recently, studies have shown that shear stress can induce differentiation of stem cells toward
both endothelial and bone-producing cell phenotypes. The current data supporting the role
of shear stress in stem cell fate and potential mechanisms and signaling cascades for trans‐
ducing shear stress into a biological signal are reviewed elsewhere [122].
In another study, it was shown that the cyclic compressive loading alone will induce chon‐
drogenic differentiation as effectively as the TGF-β alone or TGF-β plus loading in short
term culture. Regarding MSCs angiogenesis, DNA microarray experiments [123] showed
that uniaxial strain increased smooth muscle cell (SMC) markers. But cyclic equiaxial strain
downregulated SM α-actin and SM-22α in MSCs on collagen- or elastin-coated membranes
after 1 day, and decreased α-actin in stress fibers. This result suggests that uniaxial strain,
which better mimics the type of mechanical strain experienced by SMCs, may promote
MSCs differentiation into SMCs if cell orientation can be controlled. Solvig Diederichs et al.
applied singular and repetitive cyclic strain of short- and long-time strains [124]. Additional‐
ly, a gradually increasing strain scheme commencing with short-time strain and continuing
elongated strain periods was applied. Adipose tissue–derived MSCs on planar silicone and
a three-dimensionally structured collagen I mesh were exposed to these strain regimes. The
results revealed that even short-time strain can enhance osteogenic differentiation. Elonga‐
tion and repetition of strain, however, resulted in a decline of the observed short-time strain
effects, which was interpreted as positively induced cellular adaptation to the mechanically
active surroundings. With regard to cellular adaptation, the gradually increasing strain
scheme was especially advantageous.
Taken together, these results suggest that the design of ex vivo stem cell culture systems
should consider all types of mechanical cues in the microenvironment including matrix stiff‐
ness, compressive loading and shear stress as factors in guiding proper lineage specification.
2.4. Electrical stimulus and other cues
Several studies have recently shown the response of NSCs to electric fields. The studies re‐
ported by Matos et al. showed the response of murine NSCs encapsulated in alginate hydro‐
gel beads to alternating current electric fields [125]. They found an enhanced propensity for
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astrocyte differentiation over neuronal differentiation in the 1 Hz cultures. In another study,
Park et al. discovered the enhanced neuronal differentiation of hNSCs on graphene, which
had a good electrical coupling with the differentiated neurons for electrical stimulation
[126]. The application of an electrical stimulus causes fibroblasts to change cell shape and
reorient in the 3D collagen scaffold perpendicularly to the direction of electrical stimulus,
while the same electrical stimulus applied to MSCs induces much less significant reorienta‐
tion. A stimulus as strong as 10 V/cm is needed to induce a δV of 50 mV or greater, which
would be sufficient to activate voltage-gated Ca2+ channels and regulate Ca2+-dependent
sub-cellular processes, including cytoskeletal reorganization that is likely to cause changes
in the cell morphology and reorientation signaling pathways [127]. It needs to be identified
as to whether the differentiation of stem cell following adhesion will change under electrical
stimulus. Endothelial progenitor cells and muscle precursor cells can also be stimulated by
electromagnetic fields to promote myocyte differentiation [128,129]. Interestingly, electrical
stimulation (10–40 V, 5 ms, 0.5 Hz pulses) of human embryonic fibroblasts was found to
cause loss of cell proliferation and cell number but also led to differentiation of fibroblasts
into multinucleated myotube-like structures [130].
Ultrasound has also been shown to induce differentiation. In low-intensity ultrasound field
studies, MSCs differentiate towards a chondrocytic phenotype [131]. In one study, Abramo‐
vitch-Gottlib L et al. have illustrated that the use of low level laser irradiation (~0.5 mW/cm2)
applied to a MSC/coralline construct stimulates the proliferation and differentiation of MSC
into an osteoblastic phenotype during the initial culture period and significantly induced in
vitro osteogenesis over time [132]. Thus, low level laser irradiation quickens the differentia‐
tion of MSC into an osteoblastic phenotype during bone formation processes in early culture
periods.
Numerous recent papers have sprouted showing how even minor experimental modifica‐
tions can change cell phenotype. Indeed, stem cells are so sensitive and unstable that even
cell seeding density and seeding protocol have been observed to influence cell shape and
gene expression [133].
3. Some novel trends emerging in the field of tissue engineering
In the following part we will introduce some novel trends emerging in the field of tissue en‐
gineering in terms of both cellular biology (cell reprogramming) and biomaterial (multifac‐
torial design strategies) point of view in order to improve the overall efficiency of tissue
regeneration.
3.1. Cell reprogramming
Though all somatic cells of the human body have the same genome structure, differences in
chromatin organization and expression pattern of genes lead to the formation of various
types of cells with different physiology, function and morphology [134,135]. Therefore, one
could speculate that by changing chromatin structure and pattern of gene expression, all
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cells can be converted to other cell types [136]. The first cell reprogramming report has been
presented in an earlier report [137] in which fibroblast cells converted into myocyte through
the overexpression of MyoD gene. In a later study, the nucleus of the fibroblast cell has been
transferred to the enucleated oocytes which finally led to the birth of Dolly sheep [135]. Ya‐
manaka (2006) shed some light on the biology underlying cell differentiation and cell fate by
converting the mouse fibroblast to iPS cells in his study; one year later, Yamanaka and
Thompson [138-140] reported the generation of human iPS cells from fibroblast cells.
The possibility of directing lineage specific reprogramming of cells opens a window to a
vast range of new possibilities in tissue engineering and regenerative medicines [141]. Here‐
in, generation of iPS cell lines is an important issue in the way to derive pluripotent cells
from somatic cells. Instability of the genome, high cost of culture, lack of an efficient proto‐
col for differentiation as well as the presence of tumorigenic potential upon transplantation
are among the main reasons for the slow progress of its clinical application [142].
Differentiation of stem cells into different types of tissue or organ is still a major limiting fac‐
tor in the area of tissue engineering mainly due to the complexity and multicellular struc‐
ture of the tissues and organs. To overcome such a limitation, it is highly demanded to have
different types of cells for tissue engineering which is considered to be as important as mim‐
icking the physiological condition in vivo. Self-renewing and pluripotency are unique prop‐
erties of pluripotent stem cells that make the embryonic developmental process possible for
the complex and integrated tissue-engineered systems. Accordingly, to make complex and
integrated tissues, intrinsic developmental programs of inner cell mass of blastocysts such as
those of post gastrulation events can be followed. Eiraku et al. [143] in a recent study man‐
aged to recreate the 3D structure of an organ for the first time in the world. They succeeded
in growing a structure like the optic cup with the six cell types present in normal retina tis‐
sue. They mimicked aggregation and self-induction of mESCs as embryoid body and neuro‐
sphere formation to make optic cup that can be the source of retinal neurons like embryonic
process of eye formation. For this, they used genetic engineered mES with tissue specific re‐
porter RX-venues DNA construct for capturing the early stages of optic cup-cell mass forma‐
tion and their separation for more maturation. Scientists hope to begin applying the same
technologies used for retinal tissue to make 3D structure of other organs such as the brain,
lung and kidney. However, despite advances like these, it is quick to note that we can deter‐
mine as to whether pluripotent stem cells can be used for regenerative therapy. The best
idea is not always to uprise the cells to the tip of potency pyramid and then downrise it to a
low level with differentiation, whereas one can directly convert one cell type to another
[143]. It has been shown that the fibroblast cells can be converted to myocyte, neuron, hepa‐
tocyte, cardiomyocyte simply with direct reprogramming [137, 144-146]. This provides us
good tools for having wide ranges of cells for regenerative medicines [147]. New approaches
to cell reprogramming such as direct reprogramming of somatic cells to tissue-specific stem
cells and conversion of fibroblast to neural stem cells have been proposed [148]. Providing
three types of cells, namely astrocyte, oligodendrocyte and neuron, which are required in
neural systems, is the advantage of cell reprogramming [148]. Another advantage of using
direct reprogramming to tissue specific stem cells instead of reprogramming to full matured
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cells is that all types of cells which are necessary for the regenerating of that specific tissue
will be provided in the former approach. For instance, it has recently been well demonstrat‐
ed that convection of fibroblast cells to NSC is more promising than the conversion of the
same cells to the neuron [149]. Moreover, adult stem cell generation through direct reprog‐
ramming has more capacity for self-renewal, which can be expanded and stored for differ‐
ent clinical applications. Tissue specific adult stem cells are natural stem cells of any tissue
and match the normal homing tissue [149] and can respond to niche messages under both
stress and damage condition.
Human body is a complex system that works with many regulatory and check points in co‐
ordination with many flexible programs. Using direct reprogramming, progression in regen‐
erative therapy will be possible if all demanding material such as adult stem cells, ES, iPS
are well prepared in a suitable place and appropriate manner.
3.2. Multifactorial design strategies
In contrast to elements of living systems’ ECM, the designed scaffolds are very poor in infor‐
mation, which make them suboptimal for many tissue engineering applications. These pas‐
sive biomaterials are unlikely to guide cell migration and differentiation or controlled
matrix deposition, a problem that becomes even more evident in complex tissues with more
than one cell type. Furthermore, they also cannot induce tissue neo-formation while pre‐
venting other undesirable tissue repair processes such as scarring; they are also unable to
promote functional tissue integrations, such as vascular and/or nervous connectivity, in the
host. Finally, these passive scaffolds largely lack the capacity to induce cell differentiation,
thus resulting in a major limitation for their use together with current stem cell-based thera‐
pies [150]. A promising strategy to overcome these limitations is to consider the multi-factori‐
al design strategies by combining various external cues with one another for efficient and
controlled formation of complex tissues.
3.2.1. Combining structural and biological cues for scaffold bioactivation
While combining the structural and biological cues, a bioactive scaffold can be constructed
in which biological functionality has been integrated to provide an information-rich support
material for tissue engineering. Bioactive scaffolds are designed to control cell and tissue re‐
sponses, and to provide a more efficient integration with the host. Indeed, bioactive scaf‐
folds can also be prepared from synthetic materials by physical adsorption or chemical
immobilization of biomolecules or oligopeptides on the scaffold surface, or by physical en‐
trapment of bioactive molecules alone or incorporated in a drug delivery system into the
scaffold. These strategies can also be applied to enhance the bioactivity of scaffolds made
from ECM-native materials.
Engineered tissues need not only to remedy a defect and to integrate into a host tissue, but
they also need to meet the demands of a constantly changing tissue. It was hypothesized
that those tissues capable of growing with time could be engineered by supplying growth
stimulus signals to cells from the biomaterials used for cell transplantation [151]. Smart drug
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delivery system is able to transmit multiple signals to the cells in a timely controlled release
pattern. This release may be controlled through properties of the drug delivery system itself
such as biodegradation-controlled release devices or stimulisensitive systems. Polymeric
materials can be used as tissue-engineering scaffolds and drug release carriers, a strategy that
has been mainly used for soluble signaling molecules such as growth factors. Cell recruit‐
ment and migration to the site of injury may be promoted through various signaling mole‐
cules. Many of these factors, e.g. TGF-βs, BMPs and IGF-1, are not only involved in cell
attraction but also affect stem cell proliferation and differentiation [152-155].
Drug delivery strategies are designed to provide a platform for the localized delivery of the
growth factors at the site of implantation. This is to protect the bioactivity of the molecule, to
provide a controlled release pattern of the drug over a desired time frame, and deliver angio‐
genic factors so as to promote angiogenesis.
Two approaches have been mainly used for scaffold bioactivation: growth factors can be en‐
capsulated in a selected drug delivery system such as a microsphere or nanoparticle formu‐
lation, and these can be incorporated into the scaffolds. Otherwise, growth factors can be
incorporated directly into the scaffold itself [156-158]. For example, IGF-1 has been directly
incorporated into porous 3D silk fibroin scaffolds [159]. Silk scaffolds incorporating IGF-1
were able to preserve growth factor bioactivity, and prompted chondrogenic stimuli to seed‐
ed MSCs in vitro. By definition, implantation of growth factor-loaded scaffolds results in the
localized delivery of the signaling molecule. Still, a certain fraction of the incorporated drug
can reach the lymphatics or the circulation, and then distribute to non-target tissues. There‐
fore, even for these localized therapies, potential adverse effects of growth factor need to be
carefully monitored.
Silk fibroin nano-fibrous scaffolds containing BMP-2 and/or nanoparticles of hydroxyapatite
which were prepared via electrospinning were selected as matrix for in vitro bone formation
from human bone marrow derived hMSCs. Li et al. [160] reported that silk fibroin nano-fibrous
scaffolds with BMP-2 supported higher calcium deposition and enhanced transcript levels of
bone-specific markers in comparison with controls without BMP-2, suggesting that nano-fi‐
brous electrospun silk scaffolds can be an efficient delivery system for BMP-2. The mild aque‐
ous process required for electrospinning, offers an important option for delivery of labile
cytokines  and  other  biomolecules.  Lee  et  al.  reported  that  calcium  phosphate  cement
(CPC( combined with alginate solution to form a porous scaffold showed the capability to safe‐
ly load biological proteins (BSA and lysozyme) during preparation and to release them in vitro
for over a month [161]. CPC–alginate scaffolds can further be developed into tissue engineered
constructs which deliver biological molecules for bone regeneration stimulation.
In case of building biofunctionality into electrospun nano-fibers for neural tissue engineer‐
ing, the challenge to produce nano-fibers with more bioactive surfaces, significantly improv‐
ing specific targeting of cell substrate interactions and consequently creating a more
biomimetic microenvironment for implanted cells remains. There are several methods, such
as polymer blending and surface biofunctionalization, for improvement of nano-fibrous
scaffolds bioactivity for nerve tissue engineering which are reviewed elsewhere [162]. It is
possible to fabricate electrospun scaffolds from blends of synthetic and natural polymers,
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which will then have improved cell substrate interactions. The orientation of neurites from
chick embryonic dorsal root ganglia is enhanced on aligned blended polycaprolactone/colla‐
gen (PCL/collagen) (72:25) nano-fibers compared with that on aligned, pure PCL [163]. The
migration and proliferation of Schwann cells is also significantly improved on aligned PCL/
collagen nano-fibers, indicating more specific biomolecular interactions between cells and
the collagen polymers on the nano-fiber surface [164].
Instead of direct electrospinning the naturally derived polymers such as collagen together
with synthetic polymers to provide biomemitic nano-fibrous scaffolds, one can immobilize
some specific peptide motifs derived from ECM protein, which have been discerned to play
an important role in tissue regeneration to the synthetic nano-fiber surface, which provides
an alternative method to render the fibers bioactive. For instance, immobilization of mole‐
cules, such as specific peptide motifs derived from fibronectin and collagen VI, to the syn‐
thetic nano-fiber surface provides an alternative method to render the fibers bioactive.
Therefore, surface immobilization of these small molecules that are neuroactive can provide
a great advantage for neural tissue engineering. In addition, immobilized growth factors
such as brain-derived neurotrophic factor [165] and basic fibroblast growth factor [166] can
also promote cell survival and neurite outgrowth.
3.2.2. Combining structural and mechanical cues for engineering large-scale and/or complex tissues
The successful replacement of large-scale defects using tissue-engineering approaches will
likely require composite biomaterial scaffolds that have biomimetic structural and mechani‐
cal properties and can provide cell-instructive cues to control the growth and differentiation
of embedded stem or progenitor cells.
The depth-dependent composition and structure of articular cartilage gives rise to its complex,
non-homogeneous mechanical properties. Articular cartilage is generally composed of chon‐
drocytes and a dense ECM, which mainly includes type II collagen and proteoglycans [167].
Articular cartilage is structurally comprised of four different layers that can be distinguished
from one another by collagen fiber alignment and proteoglycan composition. The depth-de‐
pendent alignment of collagen leads to important tensile and shear properties, whereas the
depth-dependent proteoglycan content contributes more to the compressive properties of each
zone [168, 169]. Nguyen et al. demonstrated in a recent study that layer-by-layer organization
of specific biomaterial compositions creates 3D niches that allow a single MSC population to
differentiate into zone-specific chondrocytes and organize into a complex tissue structure [75].
The results indicated that a three-layer polyethylene glycol (PEG)-based hydrogel with chon‐
droitin sulfate (CS) and matrix metalloproteinase-sensitive peptides (MMP-pep) incorporated
into the top layer (superficial zone, PEG:CS:MMP-pep), CS incorporated into the middle layer
(transitional zone, PEG:CS) and hyaluronic acid incorporated into the bottom layer (deep zone,
PEG:HA) which ultimately created native-like articular cartilage with spatially-varying me‐
chanical and biochemical properties. They concluded that spatially-varying biomaterial com‐
positions within single 3D scaffolds can stimulate efficient regeneration of  multi-layered
complex tissues from a single stem cell population.
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In another study, the potency of scaffold stiffness and topology in driving cardiac stem cell
differentiation in a 3D culture context was confirmed by Forte et al. [170]. Cardiac stem cells
adopted the cardiomyocytic phenotype only when cultured in strictly controlled conditions
characterized by a critical combination of chemical, biochemical, structural and mechanical
factors, and emulation of the inner myocardial environment. In these studies, the mimicry of
myocardial environment was achieved by fine-tuning the array of growth factors dissolved
in the culture medium and the chemistry, topology and stiffness of three-dimensional sup‐
ports on which stem cells were seeded. Scaffold stiffness was modulated in this study by
changing the topology of the structure using a rapid prototyping technique. The optimal
stiffness to induce cardiomyocyte differentiation was around 300 kPa on the scaffolds with
square pores of about 150 μm.
4. 2D Polysaccharide-based hydrogel scaffolds for muscle tissue
engineering
Hydrogels have been used for a variety of biomedical applications [171-175], and because of
their viscoelastic characteristics [176], similarities with ECM, excellent biological perform‐
ance, inherent cellular interaction capability [177], ability to allow transfer of gases and nu‐
trients [177], and their amiability of fabrication into specific shapes, they have recently been
explored as scaffolding materials for tissue engineering applications [178-180]. On the other
hand, in the recent decade, researchers realized that the mechanical properties of the used
hydrogel material had to be adapted to the elastic properties of the damaged tissue [181].
Hydrogels such as alginate, chitosan, collagen and hyaluronic acid, which are derived from
natural polymers, have been proved to be quite promising for stem cell proliferation, main‐
tenance and differentiation for tissue engineering applications.
The authors of this paper tried to prepare hydrogels made of natural polymers (chitosan
(CS) and gelatin (G))  with proper handling for surgery,  and with mechanical  properties
similar to those of muscle tissues as well as good cell adhesion properties. In the current
study,  we  investigated  the  effect  of  CS  and  G concentration  in  blend  scaffolds  on  me‐
chanical  properties  of  the  CS-G  hydrogel  sheets  as  well  as  the  seeded  muscle-derived
stem cells (MDSCs) and smooth muscle cells’ (SMCs) behavior on the CS-G hydrogel
sheets.  MDSCs and SMCs were isolated, expanded in culture and characterized with re‐
spect to the expression of surface markers with flow cytometry analysis. After crosslink‐
ing  of  CS  and G,  the  CS-G blend hydrogel  sheets  were  prepared  by  a  casting  method
and used for 2D cell culture.
While the elasticity of  the CS-G hydrogel sheets increased by increasing the CS concen‐
tration,  the  gelatin  concentration  did  not  have  any  notable  effect  on  the  hydrogel  me‐
chanical properties.
The MDSCs attachment on the surface with elastic modulus of 25 kPa stiffness and pro‐
liferation on different CS-G hydrogel sheet surfaces having varying modulus of elasticity
is shown in Figure 2. The cell observation result on day 1 showed that by increasing the
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elasticity of hydrogel sheets, most of the cells on the hydrogel surfaces with high elastici‐
ty (E=100 kPa, CS=4.5% w/v) didn’t fully expand on the hydrogel surface, while the cells
on the hydrogel surfaces with low and intermediate elasticity (E=15 kPa, CS=1.5 % w/v;
E=25 kPa,  CS=3% w/v) had more spindle shape (data not  presented).  Gelatin concentra‐
tion was fixed (18% w/v) for all  the samples.  The greatest  proliferation of  the cells  was
found on the hydrogels with intermediate elasticity (25 kPa) and the number of cells in‐
creased  over  time  during  the  7-day  culture  (Figure2).  Hydrogel  blends  with  lower  or
higher  gelatin concentration showed significantly lower attached cell  numbers  (data not
presented).  Recent studies have illustrated the profound dependence of  cellular behavior  on
the stiffness of 2D hydrogel sheets. Boontheekul et al. demonstrated that alginate gel with
higher mechanical strength (increasing from 13 kPa to 45 kPa) increased myoblast adhe‐
sion, proliferation, and differentiation in a 2D cell culture model [182]. They also showed
that primary mouse myoblasts were more highly responsive to this cue than the C2C12
myoblast cell line.
An innovative approach has recently been described by Gilbert et al. as well. Using a bi‐
oengineered  substrate  in  conjunction  with  a  highly  automated  single-cell  tracking  algo‐
rithm, the authors  showed that  substrate  elasticity  is  a  potent  regulator  of  muscle  stem
cells'  fate in culture.  In fact,  muscle stem cells  cultured on soft  hydrogel  substrates that
mimic  the  elasticity  of  muscle  self-renew in  vitro,  and  contribute  extensively  to  muscle
regeneration when subsequently  transplanted into  mice.  This  study has  provided novel
evidence showing that recapitulating physiological tissue rigidity allows the propagation
of adult muscle stem cells [183].
In  the  current  study,  the  authors  investigated  the  behavior  of  MDSCs  and  SMCs  cul‐
tured on the prepared hydrogel surfaces.  The results indicate that increasing the hydro‐
gel  mechanical  strength  from  E=15  kPa  to  E=25  kPa,  increases  MDSCs  adhesion  and
proliferation.  The authors further found that  MDSCs were more responsive to mechani‐
cal properties of the hydrogel sheets compared to SMCs, due to their higher ability and
relatively smaller  size  (Data not  presented).  In  contrast,  for  engineering central  nervous
system tissue, Leipzig et  al.  demonstrated that gels with lower mechanical properties of
methacrylamide chitosan hydrogel  sheet  (E  ≤3.5  kPa)  were  more appropriate  for  neural
stem progenitor cell differentiation and proliferation [115]. As mentioned above, mechan‐
ical  properties  of  hydrogel  can regulate  the  cell  adhesion,  proliferation,  and differentia‐
tion.  However,  the  response and sensitivity  to  this  variable  is  highly  dependent  on the
cell  source.  In  the  current  work,  MDSCs  exhibited  maximal  proliferation  on  hydrogel
surface  with  25  kPa  elasticity.  The  same hydrogel  sheet  showed also  the  best  handling
qualities  for  surgery,  with  elasticity  in  the  range  of  elastic  modulus  for  muscle  tissues
[184], showing its potential for being used in muscle tissue engineering applications.
The strategy applied in the current study provides an opportunity to independently control
mechanical and bioadhesive properties of the hydrogels so as to probe stem cell behavior.
By changing both material mechanical and biochemical properties of the hydrogel blend, we
could find the optimum condition for MDSCs attachment and proliferation in contact with
CS-G hydrogel sheets.
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Figure 2. MDSCs adhesion and proliferation on CS-G hydrogel surfaces. Photomicrographs of MDSCs attachment on
the surface with intermediate elasticity (25kPa, CS=3 % w/v) at: (A) day 1, (B) day 7 and (C) cell proliferation on CS-G
hydrogel surfaces with different mechanical strength. CS-G hydrogel sheets prepared at different chitosan concentra‐
tion (4.5, 3 & 1.5 % w/v) with constant gelatin (18 %w/v). MDSCs were seeded onto all hydrogel surfaces at the densi‐
ty of 7500cells/cm2.
5. Conclusion and outlook for the future
In  tissue  engineering,  directing  the  cells  to  differentiate  at  the  right  time,  in  the  right
place, and into the right phenotype, requires an environment providing the same factors
that govern cellular processes in vivo.  The current chapter described various biomaterials
and external  cues  designing considerations  mimicking the  natural  stem cell  microenvir‐
onment  in  order  to  direct  the  desired stem cell  fate,  facilitating the  regeneration of  de‐
sired tissues. In addition we introduced our approach to designing a 2D polysaccharide-
based  hydrogel  scaffolds  as  a  potential  and  suitable  biomaterial  for  muscle  tissue
engineering applications.
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Overall, this chapter provides an overview of recent progresses made by application of nov‐
el engineering strategies that have been developed to emulate the stem cell niche for effec‐
tively controlling the cell fate and translating the stem cell research into much needed
clinical applications in the not-too-distant future.
Future directions in tissue engineering will involve elucidation of molecular mechanisms by
which all types of external cues influence stem cells’ behavior, followed by translation of
these scientific data to clinical applications. Further advances in controlling stem cell fate
can be achieved by combining the above mentioned parameters in a more scalable and com‐
binatorial manner to address the complexity of the natural stem cell niche. To this end, col‐
laborative efforts between cell biologists and materials scientists are critical for answering
the key biological questions and promoting interdisciplinary stem-cell researches in the di‐
rection of clinical relevance.
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